Keywords: anada, Drug approval, Medicines acces, Fraser Institute

Slow government approval policies and provincial drug plan delays limit Canadians’ access to new medicines, says think-tank

Article | 19 March 2010

Many Canadians are unable to take advantage of new prescription medicines as a result of Canada’s slow drug approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in